Blu Wireless Licenses Arteris FlexNoC Interconnect IP for HYDRA WiGig and 4G Backhaul Subsystems
Fully-featured network-on-chip (NoC) IP shortens design time, increases performance and reduces die cost and power consumption
CAMPBELL, Calif. — November 3, 2015 —Arteris Inc., the inventor and only supplier of silicon-proven commercial network-on-chip (NoC) interconnect IP solutions, today announced that Blu Wireless Technology has licensed Arteris FlexNoC interconnect IP for use in its HYDRA WiGig and 60GHz millimeter wave baseband IP.
Blu Wireless, based in Bristol, UK, designs and licenses semiconductor intellectual property to telecommunications semiconductor companies for gigabit rate wireless modems operating in the millimeter wave frequency bands.
“Our use of Arteris FlexNoC has simplified our creation of a flexible and scalable architecture to support today’s multi-gigabit communications standards, and to more easily adapt to emerging standards through the future creation of product derivatives,” said Henry Nurser, CEO of Blu Wireless. “Because we use a complex heterogeneous multiprocessing architecture, mixing fixed-function DSP blocks with highly optimized parallel vector DSPs, we required an interconnect that implements end-to-end quality of service guaranteeing our on-chip latency and bandwidth requirements. Arteris FlexNoC delivered this QoS while using less die area and power consumption than competing technologies.”
“We are excited that Blu Wireless is using Arteris FlexNoC to help it quickly create extremely complex systems-on-chip for use in the some of the world’s highest bandwidth wireless telecommunications systems,” said K. Charles Janac, President and CEO of Arteris. “We are proud to contribute to Blu Wireless’ explosive growth as it commercializes 60GHz WiGig technology.”
About Arteris
Arteris, Inc. provides Network-on-Chip interconnect IP and tools to accelerate System-on-Chip semiconductor (SoC) assembly for a wide range of applications. Rapid semiconductor designer adoption by customers such as Samsung, Altera, and Texas Instruments has resulted in Arteris being the only semiconductor IP company to be ranked in the Inc. 500 and Deloitte Technology Fast 500 lists in 2012 and 2013. Customer results obtained by using the Arteris product line include lower power, higher performance, more efficient design reuse and faster SoC development, leading to lower development and production costs. More information can be found at www.arteris.com.
About Blu Wireless Technology
Blu Wireless is a leader in 60GHz intellectual property. The company designs and licences its technology for inclusion on 802.11ad next generation WiFi (WiGig), tri-band WiFi and 4G mobile network backhaul chipsets. www.bluwirelesstechnology.com
|
Arteris Hot IP
Related News
- Blu Wireless Partners with Cadence to Offer a Complete Set of IP for WiGig and 4G Backhaul Markets
- Multiple Arteris IP FlexNoC Interconnect Licenses Purchased by VeriSilicon for Multiple Chip Designs
- Cambricon Licenses Arteris FlexNoC Interconnect IP for Machine Learning SoCs
- Montage Technology Standardizes on Arteris FlexNoC Interconnect IP Licenses for Set-Top Box (STB) Chips
- GCT Semiconductor Licenses Arteris FlexNoC Interconnect IP for LTE Digital Baseband Systems-on-Chip (SoCs)
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- SiFive and Kinara Partner to Offer Bare Metal Access to RISC-V Vector Processors
- Imagination Announces E-Series: A New Era of On-Device AI and Graphics
- Siemens to accelerate customer time to market with advanced silicon IP through new Alphawave Semi partnership
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design
![]() |
E-mail This Article | ![]() |
![]() |
Printer-Friendly Page |